Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420

Watchlist Manager
Shanghai Shyndec Pharmaceutical Co Ltd Logo
Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420
Watchlist
Price: 12.1 CNY -4.72% Market Closed
Market Cap: 16.2B CNY
Have any thoughts about
Shanghai Shyndec Pharmaceutical Co Ltd?
Write Note

Gross Margin
Shanghai Shyndec Pharmaceutical Co Ltd

37.3%
Current
40%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
37.3%
=
Gross Profit
4.3B
/
Revenue
11.6B

Gross Margin Across Competitors

Country CN
Market Cap 16.2B CNY
Gross Margin
37%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 710.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.5B USD
Gross Margin
69%
Country US
Market Cap 251.1B USD
Gross Margin
77%
Country CH
Market Cap 202.7B CHF
Gross Margin
73%
Country CH
Market Cap 183.3B CHF
Gross Margin
75%
Country UK
Market Cap 162.4B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%
No Stocks Found

Shanghai Shyndec Pharmaceutical Co Ltd
Glance View

Market Cap
16.2B CNY
Industry
Pharmaceuticals

Shanghai Shyndec Pharmaceutical Co., Ltd. principally engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 11,937 full-time employees. The company went IPO on 2004-06-16. The firm's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The firm also offers topical preparations, such as gynecological suppositories and dermatology preparations.

Intrinsic Value
20 CNY
Undervaluation 39%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
37.3%
=
Gross Profit
4.3B
/
Revenue
11.6B
What is the Gross Margin of Shanghai Shyndec Pharmaceutical Co Ltd?

Based on Shanghai Shyndec Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 37.3%.